New drug SPY003-207 tested in healthy people for first time
Knowledge-focused
Ongoing
This early-stage study tests a new drug called SPY003-207 in 59 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose of either the drug or a placebo. The main goal is to check for side effects and measure drug levels in the blood.
Phase: PHASE1 • Sponsor: Spyre Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 07:02 UTC